Authorization

Pharming Group Reports Strong Interim Financial Results for the First Nine Months of 2019

LEIDEN, Netherlands, Oct. 24, 2019/PRNewswire/ --Compared with the first nine months of 2018 (on a like-for-like basis):

Revenues up 26%, operating profit up 38%, net profit up 73%

Compared with the previous quarter ended 30 June 2019:

Revenues up 7%, operating profit up 46%, net profit up 52% (after additional a?¬2.5 million provision for contingent consideration)



Maintained cash position despite paying a a?¬17.9m upfront to secure the rights to leniolisib from Novartis

Good progress in expanding and extending the pipeline:
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Июль 2020    »
ПнВтСрЧтПтСбВс
 12345
6789101112
13141516171819
20212223242526
2728293031